2011
DOI: 10.1016/j.mib.2011.07.028
|View full text |Cite
|
Sign up to set email alerts
|

The next generation of bacteriophage therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
192
0
1

Year Published

2013
2013
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 280 publications
(205 citation statements)
references
References 58 publications
0
192
0
1
Order By: Relevance
“…This would help in targeting phages for phage therapy, which is immensely helped by their host range (30). The mosaicism of S. aureus phages is suggestive of prevalent gene exchange within this phage group.…”
Section: Discussionmentioning
confidence: 99%
“…This would help in targeting phages for phage therapy, which is immensely helped by their host range (30). The mosaicism of S. aureus phages is suggestive of prevalent gene exchange within this phage group.…”
Section: Discussionmentioning
confidence: 99%
“…The increased incidence of antibiotic resistance has led to the search for an alternative antimicrobial treatment. Phage therapy is one potential candidate for the treatment of multidrug resistant bacteria [5]. Clinical trials of bacteriophages and their derivatives as potential alternative agents for controlling multi drug resistance infection have been described in various bacterial pathogens [6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Bacteriophage phi812 from the genus Twort-like virus, subfamily Spounavirinae, can infect at least 95% of Staphylococcus aureus strains, including those strains resistant to antibiotics (2). Thus, phi812 has the potential to be used as antibacterial phage-therapy agent (3,4).…”
mentioning
confidence: 99%